FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2922339573> ?p ?o ?g. }

• W2922339573 abstract "Cholangiocarcinoma (CCA) is a highly aggressive and fatal tumor. CCA occurs in the epithelial cells of bile ducts. Due to increasing incidences, CCA accounts for 3% of all gastrointestinal malignancies. In addition to comprehensive treatments for cancer, such as surgery, chemotherapy, and radiotherapy, during the past few years, cellular immunotherapy has played an increasingly important role. As a result of our research, we have discovered the γδ T cell-based immunotherapy for CCA.A 30-year-old male ( https://www.clinicaltrials.gov/ ID: NCT02425735) was diagnosed with recurrent mediastinal lymph node metastasis after liver transplantation because of Cholangiocarcinoma (stage IV). In the course of his therapy sessions, he only received allogenic γδ T cell immunotherapy from August, 2017 through February, 2018 (8 infusions in total). γδ T cells were expanded from peripheral blood mononuclear cells (PBMCs) of healthy donor, and ~ 4 × 108 cells were adoptive transferred to the patient.In the above case report of the Cholangiocarcinoma (stage IV) patient who had received liver transplantation and afterward was diagnosed with recurrent mediastinal lymph node metastasis, we clinically proved that allogenic γδ T cell treatment had no adverse effects. We observed that allogenic γδ T cell treatments positively regulated peripheral immune functions of the patient, depleted tumor activity, improved quality of life, and prolonged his life span. After 8 γδ T cell treatments, the size of lymph nodes was remarkably reduced with activity depletion. This clinical work suggested that allogenic γδ T cell immunotherapy could be developed into a promising therapy drug for CCA." @default.
• W2922339573 created "2019-03-22" @default.
• W2922339573 creator A5004025835 @default.
• W2922339573 creator A5022681647 @default.
• W2922339573 creator A5034571415 @default.
• W2922339573 creator A5036381691 @default.
• W2922339573 creator A5037458498 @default.
• W2922339573 creator A5038014902 @default.
• W2922339573 creator A5041015485 @default.
• W2922339573 creator A5049409385 @default.
• W2922339573 creator A5053985637 @default.
• W2922339573 creator A5060272154 @default.
• W2922339573 creator A5061725934 @default.
• W2922339573 creator A5074463821 @default.
• W2922339573 creator A5074900624 @default.
• W2922339573 creator A5074918530 @default.
• W2922339573 creator A5077290418 @default.
• W2922339573 creator A5082402559 @default.
• W2922339573 date "2019-02-08" @default.
• W2922339573 modified "2023-10-15" @default.
• W2922339573 title "Allogenic Vγ9Vδ2 T cell as new potential immunotherapy drug for solid tumor: a case study for cholangiocarcinoma" @default.
• W2922339573 cites W1853392249 @default.
• W2922339573 cites W1970368087 @default.
• W2922339573 cites W1978029914 @default.
• W2922339573 cites W1992149176 @default.
• W2922339573 cites W1995930566 @default.
• W2922339573 cites W2010488416 @default.
• W2922339573 cites W2011387799 @default.
• W2922339573 cites W2012161058 @default.
• W2922339573 cites W2019832788 @default.
• W2922339573 cites W2022050925 @default.
• W2922339573 cites W2022859267 @default.
• W2922339573 cites W2025885829 @default.
• W2922339573 cites W2032504574 @default.
• W2922339573 cites W2036501031 @default.
• W2922339573 cites W2040680356 @default.
• W2922339573 cites W2043545955 @default.
• W2922339573 cites W2043756084 @default.
• W2922339573 cites W2077034954 @default.
• W2922339573 cites W2080984679 @default.
• W2922339573 cites W2093914368 @default.
• W2922339573 cites W2109606712 @default.
• W2922339573 cites W2115393755 @default.
• W2922339573 cites W2126694219 @default.
• W2922339573 cites W2136570726 @default.
• W2922339573 cites W2139558439 @default.
• W2922339573 cites W2214494869 @default.
• W2922339573 cites W2302851559 @default.
• W2922339573 cites W2337387091 @default.
• W2922339573 cites W2343618896 @default.
• W2922339573 cites W2414823976 @default.
• W2922339573 cites W2736197951 @default.
• W2922339573 cites W2749758030 @default.
• W2922339573 cites W2797796352 @default.
• W2922339573 cites W4242728800 @default.
• W2922339573 doi "https://doi.org/10.1186/s40425-019-0501-8" @default.
• W2922339573 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6368763" @default.
• W2922339573 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30736852" @default.
• W2922339573 hasPublicationYear "2019" @default.
• W2922339573 type Work @default.
• W2922339573 sameAs 2922339573 @default.
• W2922339573 citedByCount "76" @default.
• W2922339573 countsByYear W29223395732019 @default.
• W2922339573 countsByYear W29223395732020 @default.
• W2922339573 countsByYear W29223395732021 @default.
• W2922339573 countsByYear W29223395732022 @default.
• W2922339573 countsByYear W29223395732023 @default.
• W2922339573 crossrefType "journal-article" @default.
• W2922339573 hasAuthorship W2922339573A5004025835 @default.
• W2922339573 hasAuthorship W2922339573A5022681647 @default.
• W2922339573 hasAuthorship W2922339573A5034571415 @default.
• W2922339573 hasAuthorship W2922339573A5036381691 @default.
• W2922339573 hasAuthorship W2922339573A5037458498 @default.
• W2922339573 hasAuthorship W2922339573A5038014902 @default.
• W2922339573 hasAuthorship W2922339573A5041015485 @default.
• W2922339573 hasAuthorship W2922339573A5049409385 @default.
• W2922339573 hasAuthorship W2922339573A5053985637 @default.
• W2922339573 hasAuthorship W2922339573A5060272154 @default.
• W2922339573 hasAuthorship W2922339573A5061725934 @default.
• W2922339573 hasAuthorship W2922339573A5074463821 @default.
• W2922339573 hasAuthorship W2922339573A5074900624 @default.
• W2922339573 hasAuthorship W2922339573A5074918530 @default.
• W2922339573 hasAuthorship W2922339573A5077290418 @default.
• W2922339573 hasAuthorship W2922339573A5082402559 @default.
• W2922339573 hasBestOaLocation W29223395731 @default.
• W2922339573 hasConcept C10882517 @default.
• W2922339573 hasConcept C121608353 @default.
• W2922339573 hasConcept C126322002 @default.
• W2922339573 hasConcept C143998085 @default.
• W2922339573 hasConcept C1491633281 @default.
• W2922339573 hasConcept C203014093 @default.
• W2922339573 hasConcept C2776090121 @default.
• W2922339573 hasConcept C2776694085 @default.
• W2922339573 hasConcept C2777701055 @default.
• W2922339573 hasConcept C2779013556 @default.
• W2922339573 hasConcept C2911091166 @default.
• W2922339573 hasConcept C509974204 @default.
• W2922339573 hasConcept C54355233 @default.
• W2922339573 hasConcept C71924100 @default.
• W2922339573 hasConcept C86803240 @default.

• next